FDA Inspection 1120564 — Somerville Acquisitions, Inc.
The FDA completed an inspection of Somerville Acquisitions, Inc. on January 30, 2020 in Flemington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Flemington, NJ (United States)